Skip to main content
Skip to footer
Firm
Our team
Join us
Expertise
Expertise
Patents
UPC
FRAND and SEPs
Pharma and SPCs
Trade secrets
Saisie-contrefaçon
Contracts
Patent valuation
Employee inventions
All fields of expertise
Services
Patent litigation
Bringing an infringement action
Infringement defence
Invalidity action
Provisional measures
Evidence before the UPC
The FRAND undertaking
Arbitration and mediation
Advice:
Second opinion
Litigation readiness
Saisie-contrefaçon preparedness
Trade secret audit
IP due diligence
Local counsel in France
Japan and Europe
Defensible portfolio
Litigation funding
All services
Technologies
Technical fields
Electronics
Telecoms and FRAND
Pharmaceuticals
Medical devices
Chemistry
Biotechnology
Mechanical engineering
Publications
Blog
Kluwer Patent Blog
Journals and books
Speaking engagements
Patent litigation news
Consultation responses
Glossary
All publications
Le Lab
UPC Litigation Watch
UPC decisions analysed
UPC statistics
FRAND Litigation Watch
FRAND decisions analysed
Pharma Litigation Watch
Pharma decisions analysed
Subscribe to the watch
Contact
fr
en
ja
Back to blog
Category: Litigation
23 October 2026
Biogaran v. Lundbeck and the Challenger’s Burden in Second Medical Use Cases
23 October 2026
Biogaran v. Lundbeck and the Challenger’s Burden in Second Medical Use Cases
Patents
Litigation
UPC
Pharmaceuticals
Sufficiency of disclosure
12 October 2026
Compulsory licence on a patent application: an idea making its way
Patents
Litigation
Contract
Pharmaceuticals
11 October 2026
An opt-out is not a register entry: ownership and procedural choice before the UPC
Patents
Litigation
UPC
Case law
10 October 2026
Pleading the long arm: what a UPC statement of claim must carry
Patents
Litigation
Forum shopping
UPC
9 October 2026
Entering the European market: the four questions that decide the timetable
Patents
Litigation
Forum shopping
UPC
8 October 2026
Munich’s FRAND guidelines: the illusion of precision
Patents
Litigation
FRAND
UPC
7 October 2026
Patent assignment not entered in the register: the lesson of the Sony ruling
Patents
Litigation
Case law
Saisie-contrefaçon
6 October 2026
Plausibility and the right of priority: the French court faces apixaban
Patents
Litigation
Case law
Pharmaceuticals
5 October 2026
Preliminary injunctions and patent applications: the French fault line
Application for a preliminary injunction
Patents
Litigation
Case law
Pharmaceuticals
4 October 2026
Dosage inventions and inventive step: the strict reading of the French court
Patents
Litigation
Case law
Pharmaceuticals
2 October 2026
Brexit and the UPC: where British patent holders now stand
Patents
Litigation
UPC
23 September 2026
The Transitional Period and the UPC: Coordinating Two Judicial Orders
Patents
Litigation
Forum shopping
UPC
22 September 2026
Preliminary References and the UPC: the Question of Jurisdiction
Patents
Litigation
UPC
21 September 2026
Appeals before the UPC: what the figures show
Patents
Litigation
Forum shopping
UPC
20 September 2026
FRAND devant la JUB : les solutions retenues et les questions ouvertes
Patents
Litigation
FRAND
UPC
19 September 2026
SMEs and the UPC: Cost as a Barrier to Access to Justice
Patents
Litigation
UPC
18 September 2026
Procedural Uncertainty and the UPC: Provisional Measures, Evidence and Costs
Application for a preliminary injunction
Patents
Litigation
UPC
17 September 2026
The World Without the UPC: How a Successful Court Could Still Disappear
Patents
Litigation
Forum shopping
UPC
16 September 2026
G 1/25: the description as a tool for interpreting the claims
Patents
Litigation
UPC
Case law
15 September 2026
Pay-for-delay: the CJEU confirms Teva/Cephalon and defines the limits of patent settlement agreements
Patents
Litigation
Contract
Case law
Pharmaceuticals
14 September 2026
Valeo v. Bosch: the allocation of cases within the UPC, an alternative and not an exception
Patents
Litigation
Forum shopping
UPC
Case law
11 September 2026
La saisie-contrefaçon, l’arme française que les titulaires étrangers oublient
Patents
Litigation
FRAND
UPC
Pharmaceuticals
Saisie-contrefaçon
4 September 2026
The UPC's long-arm jurisdiction: how far the arm reaches, where the effect stops
Patents
Litigation
UPC
2 September 2026
The UPC did not end parallel litigation: it turned it into a weapon
Litigation
Forum shopping
UPC
1 September 2026
Damages before the UPC: from compensation to a market reference
Litigation
Damages and interests
UPC
31 August 2026
Forum shopping before the UPC: the map, the language and Article 33
Litigation
Forum shopping
UPC
25 June 2026
IP STARS 2026 : Dhenne Avocats « Other Notable Firms », Matthieu Dhenne « Patent star »
Litigation
Distinctions
1 June 2026
IAM Patent 1000 2026: Dhenne Avocats in the Bronze band, Matthieu Dhenne recommended
Litigation
Distinctions
31 March 2026
Palmarès du Droit 2026: Dhenne Avocats named laureate in patent law
Litigation
Distinctions
19 December 2023
FINGOLIMOD or the Blues of Hesitation: can preliminary injunctions be based on a patent application under French law?
Patents
Litigation
Saisie-contrefaçon